COLA: Drug challenges and desensitization
Session recorded on August 18, 2017.
Speaker: Rebecca Saff, MD, PhD
Viewers can earn credit by completing the posttest questions.
The importance of appropriate drug allergy evaluation is becoming clearer as the use of alternative medications, when not necessary, can have consequences in the treatment of certain diseases. Allergists need to understand how to appropriately evaluate a drug hypersensitivity reaction including skin testing and test dose as appropriate and when to recommend desensitization and how the procedure should be performed. This allows patients to receive the optimal treatment that is required for their disease. This video covers evaluation, options for management, indications, and risks of drug challenges and desensitization.
Practicing Allergists / Immunologists
After viewing the video recording, learners should be able to…
- Discuss how to the evaluate and manage patients with drug hypersensitivity reactions
- Consider when performing an oral drug challenge (test dose) is appropriate
- Review indications, risks and benefits of drug desensitization
Rebecca Saff, MD, PhD
Division of Rheumatology, Allergy & Immunology
Massachusetts General Hospital
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
There is no commercial support for this activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance